0001140361-16-077473.txt : 20160822
0001140361-16-077473.hdr.sgml : 20160822
20160822185259
ACCESSION NUMBER: 0001140361-16-077473
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160818
FILED AS OF DATE: 20160822
DATE AS OF CHANGE: 20160822
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANGIODYNAMICS INC
CENTRAL INDEX KEY: 0001275187
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 113146460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
BUSINESS PHONE: 5187981215
MAIL ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greiner Michael
CENTRAL INDEX KEY: 0001520392
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50761
FILM NUMBER: 161846200
MAIL ADDRESS:
STREET 1: C/O VISTAPRINT
STREET 2: 95 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc1.xml
FORM 4
X0306
4
2016-08-18
0
0001275187
ANGIODYNAMICS INC
ANGO
0001520392
Greiner Michael
14 PLAZA DRIVE
LATHAM
NY
12110
0
1
0
0
EVP and CFO
Common Stock
2016-08-18
4
A
0
10000
0
A
10000
D
Non-Qualified Stock Option (right to buy)
16.07
2016-08-18
4
A
0
100000
0
A
2017-08-18
2023-08-18
Common Stock
100000
100000
D
Performance Right
2016-08-18
4
A
0
20000
0
A
Common Stock
20000
20000
D
This acquisition of 10,000 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 10,000 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal installments beginning on August 18, 2017, such that 25% of the restricted stock units will vest on each of August 18, 2017, 2018, 2019 and 2020.
These stock options vest in four equal annual installments beginning on August 18, 2017, such that 25% of the options will vest on each of August 18, 2017, 2018, 2019 and 2020.
Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2017, 2018 and 2019. Any shares that do not vest at the end of the performance period will be forfeited.
/s/ Stephen A. Trowbridge, Attorney in Fact
2016-08-22